Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).

Authors

null

Raquibul Hannan

University of Texas Southwestern Medical Center, Dallas, TX

Raquibul Hannan , Se Eun Kim , Suzanne Cole , Elizabeth Marie Wulff-Burchfield , Andrew Wentland , Mu-Han Hannan , Payal Kapur , Daniel Shevrin , Tami Gurley , John Kent Lin , James Brugarolas , Robert D. Timmerman , Rana R. McKay , Lynne I. Wagner , Naomi B. Haas , Michael Anthony Carducci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

05863351

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr TPS489)

DOI

10.1200/JCO.2024.42.4_suppl.TPS489

Abstract #

TPS489

Poster Bd #

M10

Abstract Disclosures

Similar Posters

Poster

2021 Genitourinary Cancers Symposium

Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.

Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.

First Author: Raquibul Hannan

Poster

2019 Genitourinary Cancers Symposium

Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.

Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.

First Author: Yuanyuan Zhang

First Author: Chiachien Jake Wang